TrialEuropean urology oncology2026

Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency.

Ruben Raychaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.